These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4105053)

  • 41. Anticoagulant therapy: questions and answers.
    Sherry S
    Compr Ther; 1976 Dec; 2(12):58-65. PubMed ID: 1000925
    [No Abstract]   [Full Text] [Related]  

  • 42. [Checking of various hemostatic indices in patients with vascular diseases before and after treatment with inhibitors of platelet adhesiveness].
    Patrone F; Armani U; Boy E; Botta G; Boccaccio P
    Minerva Cardioangiol; 1975; 23(6-7):379-91. PubMed ID: 1143662
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of streptase (streptokinase) and anticoagulants on the functional state of the thrombocytes of myocardial infarct patients].
    Belousov IuB; Liusov VA
    Klin Med (Mosk); 1971 Jul; 49(7):38-43. PubMed ID: 5151428
    [No Abstract]   [Full Text] [Related]  

  • 44. [Round table discussion on current antithrombotic therapy].
    Angiologia; 1973; 25(5):215-54. PubMed ID: 4725326
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of coronary thrombosis with streptokinase].
    Tricot R; Abastado M; Valère PE; Goglin G; Souffrant G
    Arch Mal Coeur Vaiss; 1973 May; 66(5):661-71. PubMed ID: 4199982
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
    Hupkens P; Cooley BC
    Microsurgery; 1996; 17(4):226-9. PubMed ID: 9140956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How does low-dose heparin prevent thrombosis?
    O'Brien JR
    Lancet; 1980 Aug; 2(8191):420-1. PubMed ID: 6105537
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 49. Species-dependent inhibition of platelet aggregation by adenosine and dipyridamole: paradoxical potentiation in the rat.
    Philp RB
    Thromb Diath Haemorrh; 1970 Feb; 23(1):129-39. PubMed ID: 5463287
    [No Abstract]   [Full Text] [Related]  

  • 50. Editorial: Prevention of postoperative deep venous thrombosis.
    Sixma JJ
    Neth J Med; 1973; 16(6):249-53. PubMed ID: 4767764
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 52. [The value of anti-thrombosis agents in acute peripheral obstructions in the extremities].
    Schott G
    Z Arztl Fortbild (Jena); 1980 Feb; 74(4):172-4. PubMed ID: 7415263
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 54. Thrombolytic treatment of portal thrombosis.
    Malkowski P; Pawlak J; Michalowicz B; Szczerban J; Wroblewski T; Leowska E; Krawczyk M
    Hepatogastroenterology; 2003; 50(54):2098-100. PubMed ID: 14696472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Low dosage of heparin. Theoretical and practical evaluation].
    Gormsen J; Feddersen C; Clausen NT
    Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapy of the hemolytic-uremic syndrome].
    Wehinger H; Sutor HA; Schindera F; Künzer W
    Dtsch Med Wochenschr; 1974 Apr; 99(16):840-1. PubMed ID: 4828662
    [No Abstract]   [Full Text] [Related]  

  • 57. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy.
    Kincaid-Smith P; Laver MC; Fairley KF
    Med J Aust; 1970 Jan; 1(4):145-51. PubMed ID: 4907738
    [No Abstract]   [Full Text] [Related]  

  • 58. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.
    Wood S
    J Med; 1974; 5(1):7-22. PubMed ID: 4134042
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Coronary-artery thrombosis.
    Stock SL
    Lancet; 1974 Jan; 1(7848):133. PubMed ID: 4130325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.